Legal Cases for Soft-Tissue Fillers Mainly Involve Physicians

Share this content:
Legal Cases for Soft-Tissue Fillers Mainly Involve Physicians
Legal Cases for Soft-Tissue Fillers Mainly Involve Physicians

TUESDAY, Sept. 29, 2015 (HealthDay News) -- Legal cases relating to soft-tissue filler most often involve physicians, frequently relating to a non-physician performing the procedure, according to a research letter published in the October issue of the Journal of the American Academy of Dermatology.

Navid Ezra, M.D., from the Indiana University School of Medicine in Indianapolis, and colleagues examined a legal database for litigation and disciplinary actions involving soft-tissue fillers. They identified 24 legal documents: 19 cases and five disciplinary actions, which likely underrepresents the true incidence of legal events.

The researchers found that physicians were named as defendants in 13 of the 19 cases; six of the seven cases that named non-physicians involved a substance other than the reported filler being injected. Half of the legal actions resulted from a non-physician performing the procedure. The highest proportion of litigation was seen for dermatologists and plastic surgeons (17 percent for each). Most disciplinary actions reprimanded physicians for not being present while a non-physician employee performed the procedure; physicians were functioning as medical directors of medical spas in three of the five reprimands. Granuloma formation or other autoimmune reaction was the most common injury that triggered litigation. The soft tissue filler most frequently associated with litigation was Zyderm.

"The medico-legal culture is one where physicians are responsible for their physician extenders," the authors write. "Further research should evaluate whether the presence of a physician affects rate of developing complications."

Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

NIH Panel Will No Longer Review Gene Therapy Experiments

NIH Panel Will No Longer Review Gene Therapy ...

FDA will now assess gene therapy experiments and products as it does with other treatments, drugs

Doctors Remove Contact Lens Embedded in Eyelid for Years

Doctors Remove Contact Lens Embedded in Eyelid for ...

Lens was encapsulated within the upper eyelid soft tissue since childhood eye trauma

CDC: Brucellosis in Dogs Remains a Public Health Risk

CDC: Brucellosis in Dogs Remains a Public Health ...

Infection is under-recognized, may remain a threat without stronger intervention measures

is free, fast, and customized just for you!




Already a member?

Sign In Now »